Dr. Lal Path Labs

2,625.45
+12.60
(0.48%)
Market Cap
21,944.10 Cr
EPS
43.05
PE Ratio
52.39
Dividend Yield
0.69 %
52 Week High
3,653.95
52 Week low
1,943.70
PB Ratio
10.91
Debt to Equity
0.19
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from20 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy60.00 %
60.00 %
Hold10.00 %
10.00 %
Sell30.00 %
30.00 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,625.45 21,944.10 52.39 2,295.80 11.52 362 19.34 32.37
924.90 9,492.20 67.15 568.60 20.11 120 35.77 37.07
1,678.10 8,603.17 55.50 1,216.80 4.59 129 15.38 29.23
720.35 3,817.26 43.29 581.30 8.63 70 29.25 34.72
744.55 2,404.13 31.39 636.40 25.65 57 49.23 33.12
1,875.60 1,609.75 35.45 86.70 25.47 32 58.82 53.89
231.75 737.21 7.20 1,436.10 35.04 6 -1,081.25 24.38
292.00 207.28 18.44 63.00 248.07 7 133.33 55.20
131.50 91.64 71.90 36.90 6.34 1 0.00 58.58
64.60 66.50 77.24 13.60 -8.11 -3 142.86 31.47
Growth Rate
Revenue Growth
11.52 %
Net Income Growth
50.27 %
Cash Flow Change
17.39 %
ROE
35.54 %
ROCE
34.91 %
EBITDA Margin (Avg.)
14.45 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
175
193
221
210
204
229
269
215
227
257
286
270
276
302
328
305
315
350
380
342
314
277
445
466
445
621
513
509
498
511
543
500
505
555
619
557
564
623
682
622
Expenses
128
140
196
119
144
162
182
160
170
184
200
206
203
217
231
227
235
240
257
246
244
218
305
314
309
418
357
388
364
385
390
376
375
395
424
398
401
432
458
443
EBITDA
47
53
25
91
60
67
87
55
57
73
86
64
73
84
98
78
80
110
124
96
69
60
140
152
136
203
156
121
133
126
153
124
130
161
196
159
163
191
224
179
Operating Profit %
25 %
26 %
9 %
37 %
27 %
27 %
31 %
23 %
23 %
26 %
28 %
22 %
24 %
26 %
27 %
22 %
22 %
28 %
30 %
25 %
19 %
18 %
29 %
31 %
28 %
31 %
28 %
22 %
25 %
23 %
27 %
23 %
24 %
27 %
30 %
26 %
27 %
28 %
31 %
26 %
Depreciation
8
7
7
7
7
6
7
7
8
7
8
8
11
9
9
10
10
16
18
19
20
18
20
20
20
19
21
31
38
36
39
38
38
35
36
36
37
35
35
36
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
5
5
9
12
9
11
9
9
8
8
7
7
6
6
5
Profit Before Tax
39
47
18
84
53
61
80
47
49
66
78
56
62
75
88
68
69
89
102
73
45
38
117
129
111
179
131
82
84
81
103
77
83
118
152
116
120
150
183
138
Tax
10
16
11
23
18
21
27
16
17
22
27
19
22
26
31
22
22
30
21
19
13
10
30
33
26
46
34
23
21
23
30
23
26
34
42
34
34
42
52
40
Net Profit
29
31
7
61
35
40
53
31
32
44
51
36
40
50
57
46
47
59
81
55
33
28
87
96
85
134
96
58
62
58
72
54
57
84
111
82
86
108
131
98
EPS in ₹
5.28
5.61
0.99
7.37
4.17
4.88
6.47
3.78
3.80
5.40
6.19
4.39
4.88
6.00
6.92
5.56
5.72
7.14
9.77
6.56
3.94
3.45
10.34
11.44
10.10
15.87
11.49
6.93
7.41
6.97
8.64
6.37
6.84
9.95
13.16
9.77
10.13
12.79
15.52
11.60

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
475
625
764
916
1,091
1,374
1,661
2,347
2,386
2,456
Fixed Assets
150
166
190
208
209
413
447
1,369
1,305
1,228
Current Assets
282
424
511
623
814
893
1,145
875
973
1,127
Capital Work in Progress
1
4
18
10
3
11
10
15
5
6
Investments
38
64
105
145
185
164
59
66
150
114
Other Assets
286
391
452
554
694
786
1,145
898
926
1,109
Total Liabilities
475
625
764
916
1,091
1,374
1,661
2,347
2,386
2,456
Current Liabilities
112
91
74
116
138
227
274
500
470
465
Non Current Liabilities
20
24
28
8
1
93
111
310
216
105
Total Equity
343
510
662
792
951
1,054
1,276
1,537
1,700
1,885
Reserve & Surplus
260
424
577
734
890
974
1,162
1,418
1,583
1,766
Share Capital
81
83
83
83
83
83
83
83
83
84

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
8
-5
2
37
64
67
48
134
-115
97
Investing Activities
-114
-164
-137
-172
-100
-26
-212
-449
-287
-24
Operating Activities
122
159
171
197
219
284
398
447
456
535
Financing Activities
-1
0
-32
13
-55
-190
-139
136
-283
-414

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
55.23 %
55.23 %
55.23 %
55.23 %
55.23 %
55.05 %
55.05 %
55.05 %
55.03 %
55.01 %
54.61 %
54.60 %
54.60 %
54.60 %
53.92 %
53.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.00 %
1.83 %
0.00 %
0.00 %
0.00 %
26.15 %
25.42 %
26.82 %
26.82 %
DIIs
6.47 %
5.61 %
4.84 %
5.58 %
5.69 %
5.30 %
5.09 %
6.19 %
6.55 %
7.33 %
7.97 %
8.61 %
9.69 %
12.71 %
12.89 %
13.17 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.70 %
6.24 %
6.93 %
7.45 %
9.03 %
10.44 %
8.24 %
9.03 %
9.50 %
9.31 %
8.37 %
7.26 %
6.47 %
4.91 %
4.10 %
4.01 %
Others
32.60 %
32.92 %
32.99 %
31.74 %
30.05 %
29.22 %
31.63 %
27.73 %
27.09 %
28.35 %
29.05 %
29.53 %
3.09 %
2.35 %
2.27 %
2.10 %
No of Share Holders
68,845
94,123
1,25,953
1,35,068
1,71,846
1,84,508
1,71,602
1,79,636
1,80,163
1,74,444
1,60,679
1,49,901
1,46,741
1,31,189
1,16,606
1,16,236

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 3 4.5 6 12 20 12 6 18 0.00
Dividend Yield (%) 0.00 0.34 0.43 0.43 0.44 0.77 0.67 0.27 0.69 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
2 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 08, 2025, 13:26
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Feb 07, 2025, 10:20
Update On Voluntary Liquidation Of Suburban Diagnostics (India) Private Limited Wholly Owned Subsidiary
Feb 06, 2025, 17:22
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 03, 2025, 17:59
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 31, 2025, 12:45
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 30, 2025, 19:36
Integrated Filing (Financial)
Jan 30, 2025, 16:33
Announcement under Regulation 30 (LODR)-Investor Presentation
Jan 30, 2025, 14:12
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 30, 2025, 14:07
Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
Jan 30, 2025, 13:55
Change In Authorized Officials For The Purpose Of Determining Materiality Of Any Event Or Information Pursuant To Regulation 30 Of SEBI LODR
Jan 30, 2025, 13:53
In-Principle Approval Granted For Voluntary Liquidation Of Suburban Diagnostics (India) Pvt. Ltd. (Wholly Owned Subsidiary)
Jan 30, 2025, 13:50
Record Date For Declaration Of 3Rd Interim Dividend For F Y 2024-25
Jan 30, 2025, 13:48
Announcement under Regulation 30 (LODR)-Dividend Updates
Jan 30, 2025, 13:45
Board Meeting Outcome for Outcome Of Board Meeting Dated January 30 2025
Jan 30, 2025, 13:43
Financial Results For The Quarter And Nine Months Ended December 31 2024
Jan 30, 2025, 13:39
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 24, 2025, 10:20
Board Meeting Intimation for Approval Of Unaudited (Standalone And Consolidated) Financial Results For The Quarter And Nine Months Ended 31-12-2024 And To Consider The Proposal For Declaration Of 3Rd
Jan 23, 2025, 13:13
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 08, 2025, 17:22
Change In Name Of Registrar And Share Transfer Agent (RTA) Of The Company
Dec 31, 2024, 20:44
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Dec 18, 2024, 13:01

Technical Indicators

RSI(14)
Neutral
32.37
ATR(14)
Less Volatile
74.22
STOCH(9,6)
Oversold
13.81
STOCH RSI(14)
Oversold
2.11
MACD(12,26)
Bearish
-10.93
ADX(14)
Strong Trend
28.06
UO(9)
Bearish
48.95
ROC(12)
Downtrend And Accelerating
-7.68
WillR(14)
Oversold
-84.20